Background Patients with cancer may have increased mortality with COVID-19. The
cardiovascular (CV) complications of COVID-19 in cancer patients have not been described …

Aim: COVID-19 pandemic had a big impact on our life, it has revolutionized the practice of
cardiology and the organization of hospital and outpatient activities. Thus the aim of our …

Background Cancer patients have been shown to have increased mortality with COVID-19
infection, particularly those with metastases. We sought to examine the cardiovascular …

Background: Preexisting cardiovascular disease (CVD) conditions have prognostic
implications in COVID-19. Further, cancer and CVD may co-exist (Cardio-onc), leading to …

This is a promising period in oncology research, with more than 1,100 medicines and
vaccines for cancer in development by American companies alone as of May 2018. 4 …

Despite improvements in cancer survival, cancer therapy–related cardiovascular toxicity has
risen to become a prominent clinical challenge. This has led to the growth of the burgeoning …

Background While pre-existing cardiovascular disease (CVD) appears to be associated with
poor outcomes in patients with Coronavirus Disease 2019 (COVID-19), data on patients with …

Cancer is among the major causes of death globally, accounting for nearly 10 million deaths
in 2020 [1]. Advances in cancer treatment, including the development of targeted therapies …

Cardio-oncology represents the intersection of cardiology and oncology and has emerged
as a new clinical discipline in cardiovascular medicine for several reasons (Figure 1) …

Cardiovascular disease and cancer are common, and together account for most morbidity
and mortality in Westernised societies. The incidence of both heart failure and cancer …